Underuse of invasive procedures among Medicaid patients with acute myocardial infarction.

PubWeight™: 0.88‹?›

🔗 View Article (PMC 1446697)

Published in Am J Public Health on July 01, 2001

Authors

E F Philbin1, P A McCullough, T G DiSalvo, G W Dec, P L Jenkins, W D Weaver

Author Affiliations

1: Division of Cardiology, Albany Medical College, (Mail Code 44), 47 New Scotland Ave, Albany, NY 12208, USA. philbie@mail.amc.edu

Articles cited by this

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79

Validation of a combined comorbidity index. J Clin Epidemiol (1994) 19.43

The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med (1999) 17.75

Effects of race and income on mortality and use of services among Medicare beneficiaries. N Engl J Med (1996) 9.46

Racial variation in cardiac procedure use and survival following acute myocardial infarction in the Department of Veterans Affairs. JAMA (1994) 5.03

Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada. N Engl J Med (1997) 4.84

Hospital characteristics and quality of care. JAMA (1992) 4.56

Racial differences in the use of revascularization procedures after coronary angiography. JAMA (1993) 4.53

Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. N Engl J Med (1995) 4.29

Rating the appropriateness of coronary angiography--do practicing physicians agree with an expert panel and with each other? N Engl J Med (1998) 4.01

Health care for black and poor hospitalized Medicare patients. JAMA (1994) 3.74

Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project. JAMA (1995) 3.56

The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction. Myocardial Infarction Triage and Intervention Project Investigators. N Engl J Med (1993) 3.12

Blacks in the coronary artery surgery study (CASS): race and clinical decision making. Am J Public Health (1986) 2.56

Acute myocardial infarction in the Medicare population. Process of care and clinical outcomes. JAMA (1992) 2.45

Variation in the use of cardiac procedures after acute myocardial infarction. N Engl J Med (1995) 2.32

Comparison of presentation, treatment, and outcome of acute myocardial infarction in men versus women (the Myocardial Infarction Triage and Intervention Registry) Am J Cardiol (1996) 2.12

Racial and ethnic disparities in the use of cardiovascular procedures: associations with type of health insurance. Am J Public Health (1997) 1.97

ACC/AHA guidelines for coronary angiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions. Circulation (1999) 1.95

Underuse of cardiac procedures: do women, ethnic minorities, and the uninsured fail to receive needed revascularization? Ann Intern Med (1999) 1.76

Underuse of coronary revascularization procedures: application of a clinical method. J Am Coll Cardiol (1997) 1.75

Use of cardiovascular procedures among black persons and white persons: a 7-year nationwide study in patients with renal disease. Ann Intern Med (1999) 1.68

How much are we willing to pay for information about quality of care? Ann Intern Med (1997) 1.65

Resource utilization in treatment of acute myocardial infarction: staff-model health maintenance organization versus fee-for-service hospitals. The MITI Investigators. Myocardial Infarction Triage and Intervention. J Am Coll Cardiol (1995) 1.51

Influence of gender, race, and education on patient preferences and receipt of cardiac catheterizations among coronary care unit patients. Am J Cardiol (1996) 1.36

Continuing differences in the rates of percutaneous transluminal coronary angioplasty and coronary artery bypass graft surgery between elderly black and white Medicare beneficiaries. Am Heart J (1994) 1.32

Temporal changes in the care and outcomes of elderly patients with acute myocardial infarction, 1987 through 1990. JAMA (1993) 1.28

HMO vs fee-for-service care of older persons with acute myocardial infarction. Am J Public Health (1992) 1.25

Resource utilization among intensive care patients. Managed care vs traditional insurance. Arch Intern Med (1992) 1.16

Influence of payor on use of invasive cardiac procedures and patient outcome after myocardial infarction in the United States. Participants in the National Registry of Myocardial Infarction. J Am Coll Cardiol (1998) 1.16

Discrimination in health care. Ann Intern Med (1997) 1.03

The American health care system--Medicaid. N Engl J Med (1999) 1.02

Use of the hospital in a randomized trial of prepaid care. JAMA (1988) 1.00

Differences in procedure use, in-hospital mortality, and illness severity by gender for acute myocardial infarction patients: are answers affected by data source and severity measure? Med Care (1997) 0.90

Managed care for congestive heart failure: influence of payer status on process of care, resource utilization, and short-term outcomes. Am Heart J (1998) 0.88

Coronary angiography and angioplasty after acute myocardial infarction. Ann Intern Med (1997) 0.84

Articles by these authors

Apoptosis in myocytes in end-stage heart failure. N Engl J Med (1996) 6.19

Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA (2000) 6.00

The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest (1996) 5.29

Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. N Engl J Med (1999) 4.53

Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. N Engl J Med (1995) 4.29

1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1999) 4.15

Randomised controlled trial of psychological debriefing for victims of acute burn trauma. Br J Psychiatry (1997) 3.98

Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation (1995) 3.38

Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. Circulation (1999) 3.19

The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction. Myocardial Infarction Triage and Intervention Project Investigators. N Engl J Med (1993) 3.12

Absence of association between insurance copayments and delays in seeking emergency care among patients with myocardial infarction. N Engl J Med (1997) 3.12

Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation (1995) 2.97

Validity of cardiovascular disease risk factors assessed by telephone survey: the Behavioral Risk Factor Survey. J Clin Epidemiol (1993) 2.91

Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol (1995) 2.84

Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction. N Engl J Med (1996) 2.83

ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1996) 2.81

A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. Myocardial Infarction Triage and Intervention Investigators. N Engl J Med (1996) 2.73

A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction. J Am Coll Cardiol (1996) 2.60

1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation (1999) 2.58

Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. Circulation (1994) 2.53

Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument. Ann Intern Med (1997) 2.52

Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J (2002) 2.49

Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci U S A (1999) 2.42

An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: a report from a National Heart Attack Alert Program Working Group. Ann Emerg Med (1997) 2.27

Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study. Kidney Int (2008) 2.26

Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group. Circulation (1990) 2.22

Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I. Circulation (2001) 2.22

Modulation of ventricular function through gene transfer in vivo. Proc Natl Acad Sci U S A (1998) 2.19

Brief report: recognition of acute myocarditis masquerading as acute myocardial infarction. N Engl J Med (1993) 2.14

Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Report from the Pre-hospital Study Group and the Cincinnati Heart Project. Am Heart J (1990) 2.14

Comparison of presentation, treatment, and outcome of acute myocardial infarction in men versus women (the Myocardial Infarction Triage and Intervention Registry) Am J Cardiol (1996) 2.12

Incidence of and significant risk factors for aminoglycoside-associated nephrotoxicity in patients dosed by using individualized pharmacokinetic monitoring. J Infect Dis (1993) 2.10

Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries. Circulation (1995) 2.08

Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am J Med (2000) 2.00

Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med (1985) 1.99

Factors influencing survival after out-of-hospital cardiac arrest. J Am Coll Cardiol (1986) 1.99

Prediction of hospital readmission for heart failure: development of a simple risk score based on administrative data. J Am Coll Cardiol (1999) 1.89

Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. Circulation (1996) 1.87

Giant cell versus lymphocytic myocarditis. A comparison of their clinical features and long-term outcomes. Circulation (1991) 1.85

Socioeconomic status as an independent risk factor for hospital readmission for heart failure. Am J Cardiol (2001) 1.81

Gender differences in the treatment and outcome of acute myocardial infarction. Results from the Myocardial Infarction Triage and Intervention Registry. Arch Intern Med (1992) 1.80

The results of a randomized trial of a quality improvement intervention in the care of patients with heart failure. The MISCHF Study Investigators. Am J Med (2000) 1.78

Longitudinal changes in dehydroepiandrosterone concentrations in men and women. J Lab Clin Med (1998) 1.69

Length of hospital stay after acute myocardial infarction in the Myocardial Infarction Triage and Intervention (MITI) Project registry. J Am Coll Cardiol (1996) 1.67

Quality of care and hospital readmission in congestive heart failure: an explicit review process. J Card Fail (2001) 1.63

Optimal Response to Cardiac Arrest study: defibrillation waveform effects. Resuscitation (2001) 1.61

Long-term outcome in acute myocardial infarction patients admitted to hospitals with and without on-site cardiac catheterization facilities. MITI Investigators. Myocardial Infarction Triage and Intervention. Circulation (1997) 1.59

Diagnostic accuracy of antimyosin scintigraphy in suspected myocarditis. J Nucl Cardiol (1997) 1.58

Cardiac arrest treated with a new automatic external defibrillator by out-of-hospital first responders. Am J Cardiol (1986) 1.57

Differences between patients with heart failure treated by cardiologists, internists, family physicians, and other physicians: analysis of a large, statewide database. Am Heart J (2000) 1.56

Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation (2001) 1.56

Left ventricular thrombus and subsequent thromboembolism in patients with severe systolic dysfunction. Chest (2000) 1.54

The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI). Int J Artif Organs (2008) 1.53

Effect of vesnarinone on cardiac function in patients with severe congestive heart failure. Am Heart J (1998) 1.52

Resource utilization in treatment of acute myocardial infarction: staff-model health maintenance organization versus fee-for-service hospitals. The MITI Investigators. Myocardial Infarction Triage and Intervention. J Am Coll Cardiol (1995) 1.51

An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: executive summary of a National Heart Attack Alert Program Working Group Report. Ann Emerg Med (1997) 1.50

The physician's role in minimizing prehospital delay in patients at high risk for acute myocardial infarction: recommendations from the National Heart Attack Alert Program. Working Group on Educational Strategies To Prevent Prehospital Delay in Patients at High Risk for Acute Myocardial Infarction. Ann Intern Med (1997) 1.49

Inhaled nitric oxide improves exercise capacity in patients with severe heart failure and right ventricular dysfunction. Am J Cardiol (1998) 1.47

Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. J Heart Lung Transplant (1998) 1.46

Early angiography versus conservative treatment in patients with non-ST elevation acute myocardial infarction: MITI Investigators. Myocardial Infarction Triage and Intervention. J Am Coll Cardiol (2000) 1.46

Inotropic effect of nicardipine in patients with heart failure: assessment by left ventricular end-systolic pressure-volume analysis. J Am Coll Cardiol (1989) 1.44

Inspiratory muscle training in patients with chronic heart failure awaiting cardiac transplantation: results of a pilot clinical trial. Phys Ther (1997) 1.43

Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. Circulation (1998) 1.43

Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis (2001) 1.42

ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation (1996) 1.42

TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators. Circulation (1999) 1.40

Potential impact of pulmonary artery catheter placement on short-term management decisions in the medical intensive care unit. Am Heart J (1993) 1.40

Treating myocardial infarction: importance of early reperfusion. Lancet (1994) 1.39

Relationship between pulmonary artery diameter at computed tomography and pulmonary artery pressures at right-sided heart catheterization. Massachusetts General Hospital Lung Transplantation Program. Acad Radiol (1997) 1.39

Ventricular defibrillation -- a comparative trial using 175-J and 320-J shocks. N Engl J Med (1982) 1.38

Correlating factors to resident performance in an ophthalmology program. Ophthalmology (1989) 1.38

Effect of enhanced external counterpulsation on medically refractory angina patients with erectile dysfunction. Int J Clin Pract (2007) 1.38

Socioeconomic status is an important determinant of the use of invasive procedures after acute myocardial infarction in New York State. Circulation (2000) 1.34

Factors influencing the time to thrombolysis in acute myocardial infarction. Time to Thrombolysis Substudy of the National Registry of Myocardial Infarction-1. Arch Intern Med (1998) 1.31

Community-based interventions for sudden cardiac death. Impact, limitations, and changes. Circulation (1992) 1.29

Association of gender and survival in patients with acute myocardial infarction. Arch Intern Med (1997) 1.27

Amplitude of ventricular fibrillation waveform and outcome after cardiac arrest. Ann Intern Med (1985) 1.23

Considerations for improving survival from out-of-hospital cardiac arrest. Ann Emerg Med (1986) 1.21

Multicenter, randomized, controlled trial of 150-J biphasic shocks compared with 200- to 360-J monophasic shocks in the resuscitation of out-of-hospital cardiac arrest victims. Optimized Response to Cardiac Arrest (ORCA) Investigators. Circulation (2000) 1.21

Ten-year trends in hospital care for congestive heart failure: improved outcomes and increased use of resources. Arch Intern Med (2000) 1.20

Influence of race and gender on care process, resource use, and hospital-based outcomes in congestive heart failure. Am J Cardiol (1998) 1.20

Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators. Circulation (1996) 1.19

Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis. Am Heart J (1994) 1.15

Improved neurologic recovery and survival after early defibrillation. Circulation (1984) 1.14

Angiographic findigs and prognostic indicators in patients resuscitated from sudden cardiac death. Circulation (1976) 1.13

A method of assigning scores to the components of a composite outcome: an example from the MITI trial. Control Clin Trials (1992) 1.13

Ventricular fibrillation causes sudden death in Southeast Asian immigrants. Ann Intern Med (1984) 1.13

Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials. Am Heart J (2003) 1.12

A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation. J Am Coll Cardiol (1999) 1.09